Fetal T cells are first responders to infection in adults

June 20, 2018 by Krishna Ramanujan, Cornell University
T cells (pink) scanning host cells (green) for evidence of infection. Credit: Victor Segura and Rita Serda/NIH

Cornell University researchers have discovered there is a division of labor among immune cells that fight invading pathogens in the body.

The study, published in the journal Cell, finds for the first time that fetal are present in adults and have specialized roles during infection. In fact, the first immune cells made in early life are fast-acting first responders to microbes in adulthood.

These immune cells—called CD8+ T cells—come in fetal and adult varieties, which originate in separate parts of the body and are hardwired with intrinsically different properties. The current paradigm is that, around the time of birth, the body switches from making and using fetal T cells to adult T cells to defend itself. But Cornell researchers used a unique study design to show that fetal T cells persist into adulthood and have different roles than in fighting infection.

"This discovery has led to the new idea that we might be able to predict how individuals will respond to infection based on how many are present in the adult pool and isolate the fast-acting fetal-derived cells for certain therapeutic interventions, such as infections and cancer immunotherapy," said Brian Rudd, associate professor of immunology in the College of Veterinary Medicine and the paper's senior author. Norah Smith, a research associate in Rudd's lab, is the paper's first author.

In adults, newly formed T cells recognize a signature protein on a pathogen when they first encounter it. That signal then activates the T cells and equips them to fight and proliferate up to 15 times, producing up to 10 million cells in a week. Once the pathogen has been cleared, most of those adult T cells die, but up to 10 percent survive and are stored in a pool of memory cells, allowing for a rapid recall response if that same pathogen were to strike again.

Fetal-derived cells, on the other hand, are generalists and do not form into . They respond to inflammatory signals and activate faster than adult T cells, allowing them to provide a broad swath of protection against they don't specifically recognize, Rudd said.

"It's the way that the immune system hedges its bet: It has that can respond at different rates," Rudd said.

Future work will explore how genetic and environmental factors, such as diet and gut bacteria, may alter the developmental layers in the immune system.

Explore further: Infant immune systems learn fast, but have short memories

More information: Norah L. Smith et al, Developmental Origin Governs CD8 + T Cell Fate Decisions during Infection, Cell (2018). DOI: 10.1016/j.cell.2018.05.029

Related Stories

Infant immune systems learn fast, but have short memories

June 11, 2014
Forgetful immune systems leave infants particularly prone to infections, according to a new Cornell University study. Upending the common theory that weak immune cells are to blame, the study has found that infants' immune ...

Mysteries of the developing immune system have been revealed in a study of fetal dendritic cells

December 19, 2017
The fetal immune system is fully developed and functional from as early as 16 weeks gestation, but has a mechanism to keep it suppressed until after birth, according to an A*STAR-led study. Their findings could shed light ...

Fetal immune system rejects the mother in preterm labor

April 25, 2018
Preterm labor, a common pregnancy complication, has long been a mystery to scientists. But a new study from UC San Francisco shows it may sometimes happen when the fetal immune system "wakes up" too early and begins to reject ...

Infant immunity, though fleeting, found to be strong

May 28, 2014
(Medical Xpress)—"Forgetful" immune systems leave infants particularly prone to infections, claims a new Cornell study. Upending the common theory that weak immune cells are to blame, the study has found that infants' immune ...

How cellular structure orchestrates immunologic memory

March 8, 2018
With every infection or vaccination, memory cells form that the body uses to remember the pathogen. This has been known for decades – but the structure of this cellular immunologic memory has previously proven impossible ...

New way found to boost immunity in fight cancer and infections

July 19, 2017
An international research team led by Université de Montréal medical professor Christopher Rudd, director of research in immunology and cell therapy at Maisonneuve-Rosemont Hospital Research Centre, has identified a key ...

Recommended for you

New findings suggest allergic responses may protect against skin cancer

July 17, 2018
The components of the immune system that trigger allergic reactions may also help protect the skin against cancer, suggest new findings.

The immune system: T cells are built for speed

July 17, 2018
Without T cells, we could not survive. They are a key component of the immune system and have highly sensitive receptors on their surface that can detect pathogens. The exact way that these receptors are distributed over ...

Broadly acting antibodies found in plasma of Ebola survivors

July 17, 2018
Recent Ebola virus disease (EVD) outbreaks, including the 2013-2016 epidemic that ravaged West Africa and the 2018 outbreak in the Democratic Republic of the Congo, highlight the need for licensed treatments for this often-deadly ...

How protein fragments could help to tackle the cause of hay fever

July 16, 2018
Imperial researchers are looking to protein fragments to help people build up resistance to grass pollen.

Team explores diabetes drug's ability to treat RSV infection

July 13, 2018
A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis—inflammation and obstruction of the lungs' small airways. A multi-disciplinary team of Vanderbilt investigators ...

Testing suggests TORC1 inhibitors can boost immune system in the elderly

July 12, 2018
A team of researchers affiliated with Novartis Institutes for Biomedical Research and Biometrics Matters Limited, has found via testing with volunteers that TORC1 inhibitors can boost the immune system in the elderly. In ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.